High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$24.5M
$24,455,066
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $947,581x8 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
Sell to Cover
2026-03-02
$2,227,698Largex10
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $2,227,698Largex10 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
Sell to Cover
2026-02-13
$2,157,542Large
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-02-13 | $2,157,542Large | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
Sell to Cover
2026-01-12
$3,475,157Largex21
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $3,475,157Largex21 | S | Form 4 |
|
ALNY
M
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
Equity Compensation
2025-11-26
$499,756x8
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-11-26 | $499,756x8 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-13 | $1,191,300Large | M | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
10b5-1 Sell
2025-11-13
$4,512,682Largex9
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $4,512,682Largex9 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-12 | $1,814,393Largex2 | M | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
10b5-1 Sell
2025-11-12
$7,100,322Whalex11
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $7,100,322Whalex11 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
Sell to Cover
2025-10-02
$4,034,085Largex12
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $4,034,085Largex12 | S | Form 4 |